Características clínicas y para clínicas de los pacientes con fiebre manchada por Rickettsia rickettsii en Panamá (1950-1951; 2004-2018)

[Características clínicas y para clínicas de los pacientes con fiebre manchada por Rickettsia rickettsii en Panamá (1950-1951; 2004-2018)]

Carlos Daza1, Sergio Eduardo Bermúdez Castillero2

1. Hospital Materno Infantil José Domingo De Obaldía, David, Chiriquí, Panamá; 2. Entomología Médica, Instituto Conmemorativo Gorgas de Estudios de la Salud, Panamá..

Publicado: 2019-12-26

Descargas

Resumen

[Clinical and para clinical characteristics of patients with fever spotted by Rickettsia 
rickettsii in Panama (1950-1951; 2004-2017)]

 

Resumen
La fiebre manchada causada por Rickettsia rickettsii es por mucho la enfermedad transmitida por garrapatas más importante en América Latina y una de las zoonosis más relevante del continente. En Panamá esto es notorio si se considera que los casos confirmados de la misma se han registrado en dos series: 1950-1951, donde se presentaron cinco casos, donde los dos primeros fueron resultaron fatales, y de 2004-2017, donde se confirmaron 10 casos, con nueve fallecimientos. A pesar de lo anterior, la fiebre manchada causada por R. rickettsii es una enfermedad de baja prevalencia y está dentro de las enfermedades desatendidas. El diagnóstico oportuno de R. rickettsii en personas afectadas por la misma, incrementa la posibilidad de sobrevivencia del paciente; sin embargo, a pesar de su alto porcentaje de mortalidad, esta enfermedad es poco reconocida y no se cuenta con sospecha clínica. Con el objetivo de presentar sus características clínicas en Panamá, se analizan individualmente cada reportes de caso, incluyendo datos etarios, de localidad, síntomas descritos, análisis aplicados y tratamiento.   

Abstract
The spotted fever caused by Rickettsia rickettsii is by far the most important tick-borne disease in Latin America and one of the most important zoonoses in the continent. In Panama this is notorious if it is considers that the confirmed cases have been registered in two series: 1950-1951, with five cases and two fatal; and 2004-2017, with 10 cases and nine deaths. Despite the above, spotted fever caused by R. rickettsii is a disease of low prevalence and is among the neglected diseases. The timely diagnosis of R. rickettsii in people affected by it, increases the possibility of survival of the patient; however, despite its high mortality rate, this disease is poorly recognized and there is no clinical suspicion. In order to present their clinical characteristics in Panama, each reports of case is analyzed individually, including age, location, symptoms described, applied analysis and treatment.


Abstract

[Clinical and para clinical characteristics of patients with fever spotted by Rickettsia 
rickettsii in Panama (1950-1951; 2004-2017)]

 

Resumen
La fiebre manchada causada por Rickettsia rickettsii es por mucho la enfermedad transmitida por garrapatas más importante en América Latina y una de las zoonosis más relevante del continente. En Panamá esto es notorio si se considera que los casos confirmados de la misma se han registrado en dos series: 1950-1951, donde se presentaron cinco casos, donde los dos primeros fueron resultaron fatales, y de 2004-2017, donde se confirmaron 10 casos, con nueve fallecimientos. A pesar de lo anterior, la fiebre manchada causada por R. rickettsii es una enfermedad de baja prevalencia y está dentro de las enfermedades desatendidas. El diagnóstico oportuno de R. rickettsii en personas afectadas por la misma, incrementa la posibilidad de sobrevivencia del paciente; sin embargo, a pesar de su alto porcentaje de mortalidad, esta enfermedad es poco reconocida y no se cuenta con sospecha clínica. Con el objetivo de presentar sus características clínicas en Panamá, se analizan individualmente cada reportes de caso, incluyendo datos etarios, de localidad, síntomas descritos, análisis aplicados y tratamiento.   

Abstract
The spotted fever caused by Rickettsia rickettsii is by far the most important tick-borne disease in Latin America and one of the most important zoonoses in the continent. In Panama this is notorious if it is considers that the confirmed cases have been registered in two series: 1950-1951, with five cases and two fatal; and 2004-2017, with 10 cases and nine deaths. Despite the above, spotted fever caused by R. rickettsii is a disease of low prevalence and is among the neglected diseases. The timely diagnosis of R. rickettsii in people affected by it, increases the possibility of survival of the patient; however, despite its high mortality rate, this disease is poorly recognized and there is no clinical suspicion. In order to present their clinical characteristics in Panama, each reports of case is analyzed individually, including age, location, symptoms described, applied analysis and treatment.

Biografía del autor/a

Carlos Daza, Hospital Materno Infantil José Domingo De Obaldía, David, Chiriquí, Panamá

Médico Pediatra

Citas

[1] Oteo J, Nava S, de Souza R, Mattar S, Venzal J et al. Guías Latinoamericanas de la RIICER para el diagnóstico de las rickettsiosis transmitidas por garrapatas. Rev. Chil. Infec. 2014; 31: 54–65.

[2] Fournier P, Raoult D. Bacteriology, taxonomy, and phylogeny of Rickettsia. In: Raoult, D., Parola, P. (Eds.), Rickettsial diseases. D. Informa Healthcare, 2007: 1–14.

[3] Fang R, Blanton LS, Walker DH. Rickettsiae as emerging infectious agents. Clin Lab Med. 2017, 37(2): 383–400.

[4] Bermúdez, S. E., Eremeeva, M. E., Karpathy, S. E., Samudio, F., Zambrano, M. L., et al. Detection and identification of rickettsial agents in ticks from domestic mammals in eastern Panama. J. Med. Entomol. 2009, 46(4): 856-861.

[5] Paddock C, Deninson A, Lash R, Liu, Bollweg B, et al.. Phylogeography of Rickettsia rickettsii genotypes associated with fatal Rocky Mountain spotted fever. Am J Trop Med Hyg. 2014 91(3):589-97.

[6] Alvarez-Hernandez G, Candia-Plata MC, Bolado-Martínez E, Delgado-de la Mora J, Soto-Guzmán A, López-Soto LF. Clinical profile and predictors of fatal rocky mountain spotted fever in children from Sonora, Mexico. J. Ped. Infect. Dis. 2015; 34: 125–130.

[7] Labruna M, Mattar S, Nava S, et al. Rickettsioses in Latin America, Caribbean, Spain and Portugal. Revista MVZ. 2011; 16(2): 2435–2457.

[8]

[9] Bermudez SE, Troyo A. A review of the genus Rickettsia in Central America. Res. Rep. Trop. Med. 2018; 9: 103-112.

[10] Razzaq, S., & Schutze, G. E. Rocky Mountain spotted fever: a physician's challenge. Ped. Rev., 2005; 26(4): 125-130.

[11] Harrel, G, Aikawa, JK. Pathogenesis of circulatory failure in Rocky Mountain spotted fever: alterations in the blood volume and the thiocyanate space at various stages of the disease. Arch. Inter. Med, 1949. 83(3), 331-347.

[12] Harden VA. Rocky Mountain Spotted Fever: History of a Twentieth Century Disease. Baltimore: Johns Hopkins University Press; 1990.

[13] Valbuena G. Patogénesis de las rickettsiosis en las Américas. Rev MVZ. 2010; 15(1): 2004-2006.

[14]

[15] Hun L. Rickettsiosis en Costa Rica. Acta Med Costarric. 2013; 55(Suppl 1): 25–28.

[16] Walker, D. H. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers). Principles and practice of infectious diseases. 2015

[17] Bermúdez S, Domínguez L, Suárez J, Daza C, Cumbrera A, González, J. Presente y pasado de las rickettsiosis en Panamá. 2018. ISBN 978-9962-699-26-2. 30 pp.

[18] de Rodaniche EC, Rodaniche A. Spotted fever in Panama; isolation of the etiologic agent from a fatal case. Am J Trop Med Hyg. 1950; 30(4):511–517.

[19] de Rodaniche EC. Natural infection of the tick, Amblyomma cajennense, with Rickettsia rickettsii in Panama. Am J Trop Med Hyg. 1953; 2(4):696–699.

[20]

[21] Calero C, Nuñez JM, Silva-Goytía R. Rocky Mountain spotted fever in Panama; report of two cases. Am J Trop Med Hyg. 1952; 1(4):631–636.

[22] Estripeaut D, Aramburú MG, Sáez-Llorens X, et al. Rocky Mountain spotted fever, Panama. Emerg Infec Dis. 2007; 13(11):1763–1765.

[23] Tribaldos M, Zaldivar Y, Bermudez S, et al. Rocky Mountain spotted fever in Panama: A cluster description. J Infec Dev Ctries. 2011; 5:737–741.

[24]

[25] De Lucas J, García E, García G, et al. Nuevo caso de rickettsiosis humana en Panamá, a partir de evidencia serológica y clínica. Rev Méd Pan. 2013; 34:40–43.

[26] Martínez-Caballero, Moreno B, González C. et al. Descriptions of two new cases of Rocky Mountain spotted fever in Panama, and coincident infection with Rickettsia rickettsii in Rhipicephalus sanguineus s.l. in an urban locality of Panama City, Panama. Epi Infec. 146 (7): 875-878.

[27] Pachar-Lucio JV, Ruiz-Arango JA, Bermúdez Castillero SE, Rodríguez de Pachar G. Muerte inesperada por rickettsiosis: implicaciones médico-legales y epidemiológicas. Colomb Forense. 2017; 4(2): 91-98.

[28] Álvarez-Hernández G, et al. Rocky Mountain spotted fever in Mexico: past, present, and future. Lancet Infec Dis. 2017, p. e189–e196.

[29] SzabóM, Pinter A, Labruna M. 2013. Ecology, biology and distribution of spotted-fever tick vectors in Brazil. Front. Cell. Infect. Microbiol. 3:27

[30] Bermúdez SE, Castro AM, Trejos D, et al. Distribution of spotted fever group rickettsiae in hard ticks (Ixodida: Ixodidae) from Panamanian urban and rural environments (2007–2013). EcoHealth. 2016; 13(2):274–284.

[31] Silva-Goytia R, Calero C. Estudio sobre fiebre manchada, fiebre Q y tifus exantemático en el istmo de Panamá. Arch Med Panam. 1956; 5:99–106.

[32] Bermúdez S, Lyons C, García G, Zaldívar Y, Gabster A, Arteaga G. Serologic evidence of human Rickettsia infection found in three locations in Panama. Biomédica. 2013; 33(Suppl 1):31–37.

[33] Biggs, H. M., Barton Behravesh, C., Bradley, K. K., Dahlgren, F. S., et al. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis—United States: a practical guide for health care and public health professionals. 2016.

[34] Walker DH, Hawkins HK, Hudson P Fulminant Rocky Mountain spotted fever. Its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983, 107: 121-125.

[35] de Gurrola GC, Arauz JJ, Duran E, Aguilar-Medina M, Ramos-Payan R, et al. Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature. J Med Case Reports 2008; 2: 146.

×